Sunder Biomedical Tech. Co., Ltd. (4115) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sunder Biomedical Tech. Co., Ltd. (4115:TWSE), powered by AI.

Current Price
$7.76
Sector
Healthcare
What is the Sunder Biomedical Tech. Co., Ltd. stock price forecast?

Sunder Biomedical Tech. Co., Ltd. is currently trading at $7.76. View real-time AI analysis on Alpha Lenz.

What is Sunder Biomedical Tech. Co., Ltd. insider trading activity?

View the latest insider trading data for Sunder Biomedical Tech. Co., Ltd. on Alpha Lenz.

What is Sunder Biomedical Tech. Co., Ltd.'s P/E ratio?

View Sunder Biomedical Tech. Co., Ltd.'s valuation metrics on Alpha Lenz.

Sunder Biomedical Tech. Co., Ltd.

TWSE · 4115
NT$7.76+0.29(+3.88%)
Ask about Sunder Biomedical Tech. Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sunder Biomedical Tech. Co., Ltd.'s ROE is -2.1%. Explore profitability and growth together.

Ask for details

Company Overview

Sunder Biomedical Tech. Co., Ltd. is a manufacturer specializing in medical consumables and equipment, established in 1998 and headquartered in Taichung, Taiwan. The company focuses on the design, production, and distribution of a wide array of medical devices and disposable products critical to healthcare delivery. Its product portfolio includes protective goggles, meltblown nonwoven fabrics and masks, suction irrigation sets, smoke filters, endoscopic retrieval bags, blood line sets for hemodialysis, A.V. fistula needle sets, and various types of infusion and extension tubing. Additionally, Sunder Biomedical supplies medical-grade PVC compounds, components, and transducer protectors, highlighting its role as a supplier of both finished products and raw materials for the healthcare industry. The company also provides sterilization and laboratory services, catering to hospitals, clinics, and laboratories. By serving the global health technology and medical specialties market, Sunder Biomedical Tech. Co., Ltd. supports the safety and efficiency of clinical procedures and the supply chain for medical disposables, underpinning its significance in the healthcare sector with a focus on regulatory compliance, manufacturing quality, and technological innovation.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$753.45MRevenue
0.00Shares Out
0Employees

Margins

13.60%Gross
9.48%EBITDA
-2.30%Operating
-3.42%Pre-Tax
-2.16%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-10.57%Rev 3Yr
-3.72%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.25%ROA
-2.12%ROE
-1.26%ROIC

Financial Health

NT$99.23MCash & Cash Equivalents
NT$416.51MNet Debt
68.05%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sunder Biomedical Tech. Co., Ltd. (ticker: 4115) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 7.76 with a P/E ratio of -x and P/B of -x.

ROE is -2.12% and operating margin is -2.30%. Annual revenue is $753M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sunder Biomedical Tech. Co., Ltd. (4115) Stock Forecast 2026 $7.76 — Price, Financials & Analyst Targets | Alpha Lenz